KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) EPS (Weighted Average and Diluted) (2016 - 2026)

National Health Investors filings provide 18 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.82 for Q1 2026.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 10.81% to $0.82 in Q1 2026 year-over-year; TTM through Mar 2026 was $3.1, a 1.9% decrease, with the full-year FY2025 number at $3.02, down 3.51% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.82 in Q1 2026 for National Health Investors, up from $0.8 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.96 in Q4 2024 to a low of $0.05 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.74 (2025), compared with a mean of $0.68.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 76.92% in 2022 and later skyrocketed 1380.0% in 2023.
  • National Health Investors' EPS (Weighted Average and Diluted) stood at $0.05 in 2022, then skyrocketed by 1380.0% to $0.74 in 2023, then increased by 29.73% to $0.96 in 2024, then decreased by 16.67% to $0.8 in 2025, then grew by 2.5% to $0.82 in 2026.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.82 (Q1 2026), $0.8 (Q4 2025), and $0.69 (Q3 2025) per Business Quant data.